F. Métivier

发表

Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD.

G. London, A. Guérin, S. Marchais, 2008, Journal of the American Society of Nephrology : JASN.

Arterial calcifications and bone histomorphometry in end-stage renal disease.

G. London, A. Guérin, S. Marchais, 2004, Journal of the American Society of Nephrology : JASN.

Secondary hyperparathyroidism and cardiac hypertrophy in hemodialysis patients.

G. London, A. Guérin, S. Marchais, 1987, Kidney international.

Uremic cardiomyopathy: an inadequate left ventricular hypertrophy.

M. Safar, G. London, A. Guérin, 1987, Kidney international.

Association between aluminum accumulation and cardiac hypertrophy in hemodialyzed patients.

G. London, A. Guérin, S. Marchais, 1989, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients

E. M. Passos, L. Duflot, M. Brahimi, 2020, Kidney International.

Postischemic vasodilation, endothelial activation, and cardiovascular remodeling in end-stage renal disease.

M. Safar, G. London, A. Guérin, 2000, Kidney international.

Body height as a determinant of carotid pulse contour in humans

G. London, A. Guérin, B. Pannier, 1992, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

Continuous Erythropoietin Receptor Activator (C.E.R.A.) administered at extended administration intervals corrects anaemia in patients with chronic kidney disease on dialysis: a randomised, multicentre, multiple‐dose, phase II study

F. C. Dougherty, S. Niemczyk, W. Sułowicz, 2006, International journal of clinical practice.

Pathophysiology of anaemia: focus on the heart and blood vessels.

G. London, A. Guérin, B. Pannier, 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality.

G. London, A. Guérin, B. Pannier, 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

in hemodialysis patients

A. Guérin, F. Métivier, Sylvain J. Marcha, 1987 .

Cardiovascular risk in end-stage renal disease: vascular aspects.

G. London, A. Guérin, S. Marchais, 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Cardiovascular function in hemodialysis patients.

G. London, A. Guérin, S. Marchais, 1991, Advances in nephrology from the Necker Hospital.

Oxidative Stress Mediates a Reduced Expression of the Activating Receptor NKG2D in NK Cells from End-Stage Renal Disease Patients1

A. Guérin, A. Toubert, J. Berrou, 2009, The Journal of Immunology.

Rapamycin on trial

S. Achenbach, B. Cooil, D. Ropers, 1999 .

Epstein‐barr virus‐associated Hodgkin's disease following renal transplantation

J. Emile, J. Clauvel, A. Jaccard, 1994, American journal of hematology.

NKG2D in NK Cells from End-Stage Renal Expression of the Activating Receptor Oxidative Stress Mediates a Reduced

A. Toubert, J. Berrou, A. Seidowsky, 2009 .

Blockade in Uremia

M. Safar, G. London, A. Guérin, 2005 .

Arterial sti ff ening and vascular calcifications in end-stage renal disease

G. London, A. Guérin, S. Marchais, 2000 .

Inflammation, arteriosclerosis, and cardiovascular therapy in hemodialysis patients.

G. London, A. Guérin, B. Pannier, 2003, Kidney international. Supplement.

Cardiomyopathy in End‐Stage Renal Failure

G. London, A. Guérin, S. Marchais, 1989 .

Effects of antihypertensive agents on carotid pulse contour in humans.

M. Safar, G. London, A. Guérin, 1992, Journal of human hypertension.

Arteriosclerosis and Antihypertensive Response to Calcium Antagonists in End‐Stage Renal Failure

G. London, A. Guérin, S. Marchais, 1991, Journal of cardiovascular pharmacology.

Therapeutic failure of cinacalcet in a renal transplant patient presenting hyperparathyroidism with severe hypercalcaemia.

J. Haymann, D. Glotz, B. Fouqueray, 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Salt and water retention and calcium blockade in uremia.

M. Safar, G. London, A. Guérin, 1990, Circulation.

Aortic and large artery compliance in end-stage renal failure.

M. Safar, G. London, A. Guérin, 1990, Kidney international.

Kidney transplantations with HBsAg+ donors.

M. Moal, F. Métivier, A. Pruna, 1993, Transplantation proceedings.

ACUTE DEAFNESS AND DESFERRIOXAMINE

A. Guérin, S. Marchais, F. Métivier, 1985, The Lancet.

Natural Killer Cell Dysfunction in Uremia: The Role of Oxidative Stress and the Effects of Dialysis

A. Toubert, J. Berrou, F. Métivier, 2013, Blood Purification.

Assessment and significance of arterial stiffness in patients with chronic kidney disease

G. London, A. Guérin, B. Pannier, 2008, Current opinion in nephrology and hypertension.

Arterial structure and function in end-stage renal disease.

G. London, A. Guérin, S. Marchais, 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Iodine-131 Ablation Therapy for a Patient Receiving Peritoneal Dialysis

M. Toubert, F. Métivier, C. Michel, 2001, Clinical nuclear medicine.

Improving estimates of event incidence over time in populations exposed to other events: application to three large databases.

S. Chevret, E. Thervet, P. Landais, 2003, Journal of clinical epidemiology.

Pregnancy in kidney transplantation: past and present experience.

L. Bererhi, F. Métivier, A. Marrast, 1997, Transplantation proceedings.

Arterial stiffening and vascular calcifications in end-stage renal disease.

G. London, A. Guérin, S. Marchais, 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Pefloxacin as first-line treatment in nephrotic syndrome

D. Nochy, P. Druet, C. Saltiel, 1992, The Lancet.

Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia

G. London, A. Guérin, S. Marchais, 2005, Current opinion in nephrology and hypertension.

Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study.

J. Blacher, M. Safar, G. London, 2001, Journal of the American Society of Nephrology : JASN.

Cardiac and arterial interactions in end-stage renal disease.

M. Safar, G. London, A. Guérin, 1996, Kidney international.

[Cinacalcet impact on calcium homeostasis and bone remodeling in 13 renal transplanted patients with hyperparathyroidism and hypercalcaemia].

J. Haymann, M. Flamant, D. Glotz, 2012, Nephrologie & therapeutique.

Impairment of arterial function in chronic renal disease: prognostic impact and therapeutic approach.

G. London, A. Guérin, S. Marchais, 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Association of hyperphosphataemia with haemodynamic disturbances in end-stage renal disease.

G. London, A. Guérin, S. Marchais, 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Arterial structural and functional alterations in uraemia

A. Guérin, S. Marchais, F. Métivier, 2005, European journal of clinical investigation.

Cardiac hypertrophy and arterial alterations in end-stage renal disease: hemodynamic factors.

G. London, A. Guérin, B. Pannier, 1993, Kidney international. Supplement.

Contributive factors to cardiovascular hypertrophy in renal failure.

G. London, A. Guérin, S. Marchais, 1989, American journal of hypertension.

Fungal mycotic aneurysms and visceral infection due to Scedosporium apiospermum in a kidney transplant patient.

B. Fouqueray, F. Métivier, A. Pruna, 1993, Transplantation proceedings.

Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD.

G. London, A. Guérin, S. Marchais, 2008, Journal of the American Society of Nephrology.

Epstein‐barr virus‐associated Hodgkin's disease following renal transplantation

J. Emile, J. Clauvel, F. Métivier, 1994, American journal of hematology.